摘要
目的探讨膈肌深呼吸训练辅助药物治疗支气管哮喘慢性持续期患儿的临床疗效。方法选取2018年6月—2020年1月咸宁市某医院收治的200例支气管哮喘慢性持续期患儿,采用随机数字表法分为观察组与对照组,每组100例。对照组患儿给予药物雾化吸入治疗,观察组患儿在对照组基础上给予膈肌深呼吸训练辅助治疗。比较2组患儿的临床疗效,治疗前后实验室指标、肺功能及家属满意度。结果观察组患儿治疗总有效率为95.00%,高于对照组的79.00%,差异有统计学意义(χ^(2)=11.317,P<0.05)。2组患儿治疗后血清免疫球蛋白E(IgE)、白介素-4(IL-4)及肿瘤坏死因子α(TNF-α)水平低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05)。2组患儿治疗后FEV 1、FVC及PEF水平高于治疗前,且观察组高于对照组,差异均有统计学意义(P<0.05)。观察组患儿家属满意度为94.00%,高于对照组的77.00%,差异有统计学意义(χ^(2)=11.656,P<0.05)。结论膈肌深呼吸训练辅助药物治疗慢性持续期支气管哮喘患儿疗效确切,能有效提高机体免疫能力,改善肺功能,缓解哮喘症状,提高满意度。
Objective To explore the clinical efficacy of applying diaphragmatic deep breathing training as an adjunct to medication in the treatment of children with chronic persistent bronchial asthma.Methods Two hundred cases of children with chronic persistent bronchial asthma admitted to a hospital in Xianning from June 2018 to January 2020 were selected and divided into observation group and control groups using the random number table method,with 100 cases in each group.The children in the control group were given drug nebulizer inhalation treatment,and the children in the observation group were given diaphragmatic deep breathing training on the basis of the control group.The clinical efficacy,laboratory indexes,pulmonary function and family satisfaction of the children in the two groups were compared.Results The total effective rate of treatment for the children in the observation group was 95.00%,which was higher than that of the control group(79.00%),and the difference was statistically significant(χ^(2)=11.317,P<0.05).The serum immunoglobulin E(IgE),interleukin-4(IL-4)and tumor necrosis factorα(TNF-α)levels of the children in the two groups were lower than those before treatment,and the differences were statistically significant(P<0.05).After treatment,FEV 1,FVC and PEF of children in both groups were higher than before treatment,and they were significantly higher in the observation group than in the control group(P<0.05).The satisfaction rate of the families of the children in the observation group was 94.00%,which was higher than that of the control group(77.00%),and the difference was statistically significant(χ^(2)=11.656,P<0.05).Conclusion Diaphragmatic deep breathing training is an effective adjunct to medication when treating children with chronic persistent bronchial asthma,which can effectively improve the body′s immunity,improve lung function,promote the relief of asthma symptoms and increase satisfaction.
作者
刘波
曹欣
Liu Bo;Cao Xin(Xian′an District Maternal and Child Health Hospital,Xianning Hubei 437000,China;Hubei Provincial Maternal and Child Health Hospital,Wuhan 430070,China)
出处
《保健医学研究与实践》
2022年第2期51-54,共4页
Health Medicine Research and Practice
关键词
小儿支气管哮喘
慢性持续期
膈肌深呼吸训练
药物治疗
Pediatric bronchial asthma
Chronic persistent phase
Diaphragmatic deep breathing training
Medication